Tristan joined Gilde Healthcare in 2022. He focuses on the therapeutics sector and is primarily involved in deal sourcing, due diligence, and portfolio management.

Before joining Gilde, Tristan was an Investment Analyst at Aescap, specializing in publicly listed European and US based biotech companies. Prior to this, he gained experience as Venture Capital Analyst at Andera Partners where he helped evaluate investment opportunities, deal engineering, sector landscaping studies, and fund reporting for the firm’s biodiscovery fund.

Tristan holds a Doctor of Pharmacy degree (PharmD) from Université Grenoble Alpes in France and a Master’s degree in Management from ESSEC Business School in Paris, France.